The off-patent medicines industry is a vital part of the solution for healthcare resilience
30 de junio de 2022, Sitges, España Health systems face tremendous challenges across Europe. The management of COVID-19, war in Ukraine and high inflation rates are challenging supply chains for the most essential medicines. Off patent medicines account for 70% of...
Medicines For Europe holds its annual conference in Spain this year
We encourage all those interested in the debate on the sustainability of medicine markets, shortages and security of supply and intellectual property reforms to join us together with Aeseg and us in Sitges (Barcelona) next 29 June – 1 July 2022, during the 27th...
How does chemistry get antibiotics from microorganisms?
Feique, Foro Química y Sociedad and the educational channel Unicoos, created by the professor, Youtuber and scientific disseminator David Calle, have published the twentieth video of the collection #UniQoos with Chemistry: From microorganisms to antibiotics this time,...
Generic medicines and active pharmaceutical ingredients manufacturers prepare to apply the SPC waiver
Joint information day OEPM, AESEG and AFAQUIM Next July 2nd, the exception for the SPC waiver comes into force to respond to the competitive disadvantage of generic medicines manufacturers established in the EU compared to third country producers. The SPC waiver will...
Elisabeth Stampa, new president of Medicines for Europe, the association of the European pharmaceutical industry of generic, biosimilar and value-added medicines
Announcement of the Medicines for Europe of which AFAQUIM is affiliate member. Medicines for Europe, the association representing the pharmaceutical industry of generic, biosimilar and value-added medicines throughout Europe, announced today the appointment of...
